alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 31.b

I, Marc N. Teal, certify that:

1. I have reviewed this quarterly report on Form 10-Q of BCTC V Assignor Corp. (the "Assignor");
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:



1. designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
2. evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
3. disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and



1. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):



1. all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
2. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



|August 12, 2005 | /s/ Marc N. Teal                                    
|--------------- | ----------------------------------------------------
|                | Marc N. Teal                                        
|                | (Principal Financial Officer), BCTC V Assignor Corp.
|                |
Blake Clinton TALMAN, Petitioner, v. FLORIDA.

No. 19-5909

Supreme Court of the United States.

October 15, 2019

*410Petition for writ of certiorari to the District Court of Appeal of Florida, Second District denied.
# C_2018128EN.01000101.xml

| 11.4.2018 | EN | Official Journal of the European Union | C 128/1 |
| --- | --- | --- | --- |

11.4.2018

EN

Official Journal of the European Union

C 128/1

---

Non-opposition to a notified concentration

(Case M.8839 — GIP/NTV)

(Text with EEA relevance)

(2018/C 128/01)

On 4 April 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

1

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8839. EUR-Lex is the online access to European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8839. EUR-Lex is the online access to European law.

---

(1)  OJ L 24, 29.1.2004, p. 1.

1

---
I 

113TH CONGRESS 

1ST SESSION H. R. 1052 

To extend the temporary suspension of duty on Disperse Red 167:1. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 11, 2013 

Mr. WATT introduced the following bill; which was referred to the Committee 

on Ways and Means 

A BILL 

To extend the temporary suspension of duty on Disperse 

Red 167:1. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. DISPERSE RED 167:1. 

4 (a) IN GENERAL.—Heading 9902.03.47 of the Har5 monized Tariff Schedule of the United States (relating to 

6 Disperse Red 167:1) is amended by striking the date in 

7 the effective period column and inserting ‘‘12/31/2016’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) applies to goods entered, or withdrawn from 


jbell on DSK7SPTVN1PROD with BILLS
2 

•HR 1052 IH

1 warehouse for consumption, on or after the 15th day after 

2 the date of the enactment of this Act. 

Æ 


jbell on DSK7SPTVN1PROD with BILLS
```
 
 
VIX FUTURES - CBOE FUTURES EXCHANGE                                  Code-1170E1
OPTION AND FUTURES COMBINED POSITIONS AS OF 03/11/14          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
($1000 X INDEX)                                      OPEN INTEREST:      355,040
COMMITMENTS
 114,455  121,309   96,982  123,211  109,402  334,648  327,693   20,392   27,347

CHANGES FROM 03/04/14 (CHANGE IN OPEN INTEREST:     -7,956)
  10,310   -3,282   -6,258  -11,427    2,723   -7,375   -6,817     -581   -1,139

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
    32.2     34.2     27.3     34.7     30.8     94.3     92.3      5.7      7.7

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      183)
      59       64       81       40       42      146      153
```

----

Updated March 18, 2014
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Antitrust Division
 Section 7A of the Clayton Act, 15 U.S.C. 18a, as added by Title II of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, requires persons contemplating certain mergers or acquisitions to give the Federal Trade Commission and the Assistant Attorney General advance notice and to wait designated periods before consummation of such plans. Section 7A(b)(2) of the Act permits the agencies, in individual cases, to terminate this waiting period prior to its expiration and requires that notice of this action be published in the 
                    **Federal Register**
                    . The following transactions were granted early termination—on the date indicated—of the waiting period provided by law and the premerger notification rules. The listing includes the transaction number and the parties to the transaction. The Federal Trade Commission and the Assistant Attorney General for the Antitrust Division of the Department of Justice made the grants. Neither agency intends to take any action with respect to this proposed acquisitions during the applicable waiting period. Early Termination Granted
**06/03/2022**20220800
G
General Dynamics Corporation; Walter P. Kitonis, III; Progeny Systems Corporation.20212748
G
The Big Sky Trust; Welbilt, Inc.
 Suzanne Morris, Chief, Premerger and Division Statistics, Antitrust Division, Department of Justice.


[FR Doc. 2022-12626 Filed 6-10-22; 8:45 am] BILLING CODE 4410-11-P
David BRENNAN, Petitioner v. WHITE COUNTY, ARKANSAS

No. 19-328

Supreme Court of the United States.

October 15, 2019

Petition for writ of certiorari to the Court of Appeals of Arkansas denied.
```
 
 
VIX FUTURES - CBOE FUTURES EXCHANGE                                  Code-1170E1
OPTION AND FUTURES COMBINED POSITIONS AS OF 07/08/14          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
($1000 X INDEX)                                      OPEN INTEREST:      457,197
COMMITMENTS
 147,952  218,779  101,275  176,258  103,598  425,485  423,652   31,712   33,545

CHANGES FROM 07/01/14 (CHANGE IN OPEN INTEREST:      7,361)
     245    7,637    4,774      618   -6,848    5,637    5,563    1,724    1,798

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
    32.4     47.9     22.2     38.6     22.7     93.1     92.7      6.9      7.3

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      211)
      70       83       79       39       39      152      167
```

----

Updated July 11, 2014
```
 
 
VIX FUTURES - CBOE FUTURES EXCHANGE                                  Code-1170E1
OPTION AND FUTURES COMBINED POSITIONS AS OF 03/04/14          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
($1000 X INDEX)                                      OPEN INTEREST:      362,996
COMMITMENTS
 104,145  124,591  103,240  134,638  106,679  342,023  334,510   20,973   28,486

CHANGES FROM 02/25/14 (CHANGE IN OPEN INTEREST:     -4,046)
  -4,594     -186    4,633   -3,720   -8,181   -3,681   -3,734     -365     -312

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
    28.7     34.3     28.4     37.1     29.4     94.2     92.2      5.8      7.8

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      177)
      56       62       81       41       42      145      150
```

----

Updated March 7, 2014
# C_2018030EN.01001001.xml

| 26.1.2018 | EN | Official Journal of the European Union | C 30/10 |
| --- | --- | --- | --- |

26.1.2018

EN

Official Journal of the European Union

C 30/10

---

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 December 2017 to 31 December 2017

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1) or Article 38 of Directive 2001/82/EC (2))

1

2

(2018/C 030/02)

—   Refusal of a national marketing authorization

Refusal of a national marketing authorization

| Date of the decision | Name(s) of the medicinal product | INN (International Non-Proprietary Name) | Holder(s) of the marketing authorization | Member State concerned | Date of notification |
| --- | --- | --- | --- | --- | --- |
| 18.12.2017 | Alcover and associated names — Art 29 | Sodium oxybate | — | — | 19.12.2017 |

Date of the decision

Name(s) of the medicinal product

INN (International Non-Proprietary Name)

Holder(s) of the marketing authorization

Member State concerned

Date of notification

18.12.2017

Alcover and associated names — Art 29

Sodium oxybate

—

—

19.12.2017

---

(1)  OJ L 311, 28.11.2001, p. 67.

1

(2)  OJ L 311, 28.11.2001, p. 1.

2

---
# C_2017109EN.01000301.xml

| 7.4.2017 | EN | Official Journal of the European Union | C 109/3 |
| --- | --- | --- | --- |

7.4.2017

EN

Official Journal of the European Union

C 109/3

---

Notice for the attention of the persons and entities subject to the restrictive measures provided for in Council Decision (CFSP) 2016/849 and Council Regulation (EC) No 329/2007 concerning restrictive measures against the Democratic People’s Republic of Korea

(2017/C 109/03)

The following information is brought to the attention of Mr CHON Chi Bu (No 1), Mr CHU Kyu-Chang (No 2), Mr HYON Chol-hae (No 3), Mr KIM Yong-chun (No 4), Mr O Kuk-Ryol (No 5), Mr PAEK Se-bong (No 6), Mr PAK Jae-gyong (No 7), Lieutenant General KIM Yong Chol (No 11), Mr PAK To-Chun (No 12), Mr CHOE Yong-ho (No 14), Mr JO Kyongchol (No 17), Mr KIM Chun-sop (No 19), Mr KIM Jong-bak (No 20), Mr KIM Rak Kyom (No 21), Mr KIM Won-hong (No 22), Mr YUN Jong-rin (No 26), Mr PAK Yong-sik (No 27), Mr HONG Yong Chil (No 28), persons appearing in Section I of Annex II to Council Decision (CFSP) 2016/849 (1) and in Annex V to Council Regulation (EC) No 329/2007 (2) concerning restrictive measures against the Democratic People’s Republic of Korea, as well as to the attention of Mr JON Il-chun (No 1), Mr KIM Tong-un (No 2), persons appearing Annex II to Decision (CFSP) 2016/849 and in Annex V to Regulation (EC) No 329/2007 concerning restrictive measures against the Democratic People’s Republic of Korea.

1

2

The Council intends to maintain the restrictive measures against the abovementioned persons with amended statements of reasons. Those persons are hereby informed that they may submit a request to the Council to obtain the intended statement of reasons before 17 April 2017, to the following address:

| Council of the European Union |
| --- |
| General Secretariat |
| DG C 1C |
| Rue de la Loi/Wetstraat 175 |
| 1048 Bruxelles/Brussel |
| BELGIQUE/BELGIË |
| email: sanctions@consilium.europa.eu |

Council of the European Union

General Secretariat

DG C 1C

Rue de la Loi/Wetstraat 175

1048 Bruxelles/Brussel

BELGIQUE/BELGIË

email: sanctions@consilium.europa.eu

---

(1)  OJ L 141, 28.5.2016, p. 79.

1

(2)  OJ L 88, 29.3.2007, p. 1.

2

---
```
 
 
CRUDE OIL, LIGHT SWEET-WTI - ICE FUTURES EUROPE                      Code-067411
FUTURES ONLY POSITIONS AS OF 05/13/14                         |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  LONG  | SHORT  |SPREADS |  LONG  | SHORT  |  LONG  | SHORT  |  LONG  | SHORT
--------------------------------------------------------------------------------
(CONTRACTS OF 1,000 BARRELS)                         OPEN INTEREST:      499,211
COMMITMENTS
  81,033   32,105  114,110  285,183  335,842  480,326  482,057   18,885   17,154

CHANGES FROM 05/06/14 (CHANGE IN OPEN INTEREST:    -12,758)
    -568   -7,150    5,915  -18,915  -13,973  -13,568  -15,208      810    2,450

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADERS
    16.2      6.4     22.9     57.1     67.3     96.2     96.6      3.8      3.4

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      138)
      29       37       51       69       63      129      121
```

----

Updated May 16, 2014
HONG TANG, Petitioner, v. UNIVERSITY OF BALTIMORE, et al.

No. 19-1122.

Supreme Court of the United States.

May 18, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
Luzetha WARDRICK, Petitioner, v. Brooks BENTON, Warden, et al.

No. 18-9125

Supreme Court of the United States.

October 7, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
Steven M. LEONHART, Petitioner, v. Tim SHOOP, Warden.

No. 19-7954.

Supreme Court of the United States.

May 18, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
[ARTICLE] 6
[CIK] 0000089558
[NAME] SMITH BARNEY APPRECIATION GROWTH FUND INC. - CLASS B
<TABLE>
<S>                             <C>
[PERIOD-TYPE]                   YEAR
[FISCAL-YEAR-END]                          DEC-31-1999
[PERIOD-END]                               DEC-31-1999
[INVESTMENTS-AT-COST]                    3,848,429,517
[INVESTMENTS-AT-VALUE]                   5,608,832,798
[RECEIVABLES]                               31,102,715
[ASSETS-OTHER]                             577,576,527
[OTHER-ITEMS-ASSETS]                                 0
[TOTAL-ASSETS]                           6,217,512,040
[PAYABLE-FOR-SECURITIES]                    20,898,204
[SENIOR-LONG-TERM-DEBT]                              0
[OTHER-ITEMS-LIABILITIES]                  587,617,483
[TOTAL-LIABILITIES]                        608,515,687
[SENIOR-EQUITY]                                      0
[PAID-IN-CAPITAL-COMMON]                 3,659,597,851
[SHARES-COMMON-STOCK]                      112,123,341
[SHARES-COMMON-PRIOR]                      101,776,160
[ACCUMULATED-NII-CURRENT]                      675,106
[OVERDISTRIBUTION-NII]                               0
[ACCUMULATED-NET-GAINS]                    188,320,115
[OVERDISTRIBUTION-GAINS]                             0
[ACCUM-APPREC-OR-DEPREC]                 1,760,403,281
[NET-ASSETS]                             5,608,996,353
[DIVIDEND-INCOME]                           52,974,530
[INTEREST-INCOME]                           46,144,932
[OTHER-INCOME]                                       0
[EXPENSES-NET]                              61,420,472
[NET-INVESTMENT-INCOME]                     37,698,990
[REALIZED-GAINS-CURRENT]                   597,948,936
[APPREC-INCREASE-CURRENT]                   89,842,578
[NET-CHANGE-FROM-OPS]                      725,490,540
[EQUALIZATION]                                       0
[DISTRIBUTIONS-OF-INCOME]                    2,454,139
[DISTRIBUTIONS-OF-GAINS]                   176,185,762
[DISTRIBUTIONS-OTHER]                                0
[NUMBER-OF-SHARES-SOLD]                     23,143,005
[NUMBER-OF-SHARES-REDEEMED]                 23,923,636
[SHARES-REINVESTED]                         11,127,812
[NET-CHANGE-IN-ASSETS]                     683,031,590
[ACCUMULATED-NII-PRIOR]                        (9,654)
[ACCUMULATED-GAINS-PRIOR]                (141,482,128)
[OVERDISTRIB-NII-PRIOR]                              0
[OVERDIST-NET-GAINS-PRIOR]                           0
[GROSS-ADVISORY-FEES]                       29,764,149
[INTEREST-EXPENSE]                                   0
[GROSS-EXPENSE]                             61,420,472
[AVERAGE-NET-ASSETS]                     1,682,264,485
[PER-SHARE-NAV-BEGIN]                            15.26
[PER-SHARE-NII]                                   0.03
[PER-SHARE-GAIN-APPREC]                           2.08
[PER-SHARE-DIVIDEND]                              0.00
[PER-SHARE-DISTRIBUTIONS]                         1.69
[RETURNS-OF-CAPITAL]                              0.00
[PER-SHARE-NAV-END]                              15.66
[EXPENSE-RATIO]                                   1.70
</TABLE>
Lamarr T. CRITTENDEN, Petitioner v. Keith BUTTS, Warden.

No. 19-5858

Supreme Court of the United States.

November 4, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Seventh Circuit denied.
**Exhibit 32.2**

 

**GreenPoint FinancialCorp. and Subsidiaries**

**CertificationPursuant to 18 U.S.C. Section 1350, as Adopted**

**Pursuant to Section906 of the Sarbanes-Oxley Act of 2002**

 

In connection with the Quarterly Report onForm 10-Q of GreenPoint Financial Corp. for the quarter ended March 31,2004 as filed with the Securities and Exchange Commission (the “Report”), I, Jeffrey R. Leeds, Executive VicePresident and Chief Financial Officer of GreenPoint Financial Corp. (the “Company”), certify, pursuant to 18 U.S.C.Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of2002, that:

 

(1)                                  The Report fullycomplies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)                                  The informationcontained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.

 
| Dated:  May 7, 2004 |                         |
|--------------------------|------------------------------|
|                     |                         |
|                     | /s/ Jeffrey R. Leeds         |   |
|                     | Jeffrey R. Leeds             |
|                     | Executive Vice President and |
|                     | Chief Financial Officer      |
|                     | GreenPoint Financial Corp.   |

 

#### **A signed original of this written statement requiredby Section 906 has been provided to GreenPoint Financial Corp. and will beretained by GreenPoint Financial Corp. and furnished to the Securities andExchange Commission or its staff upon request.**

#### ** **

Note: The certification theregistrant furnishes in this exhibit is not deemed “filed” for purposes ofSection 18 of the Securities Exchange Act of 1934, as amended, or otherwisesubject to the liability of that Section. Such certification will not be deemedto be incorporated by reference into any filing under the Securities Act of1933, as amended, or the Securities Exchange Act of 1934, as amended, except tothe extent that the registrant specifically incorporates it by reference.

 

1

----